You are here: Industry Insights > Moderna

News List

Lonza Congratulates Moderna on Interim Phase 3 Clinical Trial Data americanpharmaceuticalreview
November 26, 2020
Lonza has released the following statement congratulating Moderna on its recent clinical trial:“We congratulate Moderna on this important milestone, which represents a significant scientific achievement and serves as a testament to Moderna’s commitment ..
EU reaches deal to procure 160 million doses of Moderna’s Covid-19 vaccine candidate pharmaceutical-technology
November 25, 2020
The European Union has reached a deal to procure up to 160 million doses of US biotech Moderna’s experimental Covid-19 vaccine candidate.
EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine expresspharma
November 25, 2020
The European Commission (EU) has reached a deal with US biotech firm Moderna for the supply of its COVID-19 vaccine candidate, an EU official told Reuters.
UK strikes deal for five million doses of Moderna’s COVID-19 vaccine pharmatimes
November 18, 2020
The UK government has secured access to five million doses of Moderna’s COVID-19 vaccine after interim data, released yesterday, suggested that the shot is 94.5% effective.
EMA begins rolling review of Moderna’s COVID-19 vaccine candidate expresspharma
November 18, 2020
Moderna also announced a supply agreement with the UK government to supply mRNA-1273, if approved for use by MHRA.
Moderna COVID-19 Vaccine Candidate Meets Primary Efficacy Endpoint americanpharmaceuticalreview
November 17, 2020
Moderna announced the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the ...
Vaccine is 94.5 per cent effective in preventing COVID-19: Moderna expresspharma
November 17, 2020
Moderna said its experimental vaccine was 94.5 per cent effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second US company to report results that far exceed expectations.
Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData expresspharma
November 17, 2020
While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will wane.
Swissmedic Begins Rolling Review of Moderna’s mRNA COVID-19 Vax contractpharma
November 16, 2020
Moderna completed enrollment of its Phase 3 COVE study of mRNA-1273 on October 22.
Moderna partners with Takeda for Covid-19 vaccines supply to Japan pharmaceutical-technology
November 02, 2020
Moderna has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical agreed to purchase and distribute 50 million doses of its Covid-19 vaccine candidate, mRNA-1273.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page